Hillsdale Investment Management’s BioTelemetry, Inc. BEAT Stock Holding History

Hillsdale Investment Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-9,300	Closed	-$582K	–	700
2019 Q1	$582K	Buy	9,300 +2,000	+27%	+$137K	0.05%	252
2018 Q4	$436K	Buy	+7,300	New	+$438K	0.05%	287
2017 Q1	–	Sell	-45,400	Closed	-$1.01M	–	575
2016 Q4	$1.01M	Buy	45,400 +18,800	+71%	+$368K	0.21%	115
2016 Q3	$494K	Hold	26,600	–	–	0.13%	135
2016 Q2	$434K	Buy	+26,600	New	+$391K	0.13%	126
2016 Q1	–	Sell	-19,900	Closed	-$232K	–	589
2015 Q4	$232K	Buy	19,900 +7,800	+64%	+$98.7K	0.09%	284
2015 Q3	$148K	Buy	+12,100	New	+$154K	0.05%	355

Other funds holding BEAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hillsdale Investment Management's BEAT Position: Q2 2019 in Review

Hillsdale Investment Management sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 9,300 shares — an estimated $582K sold.

Hillsdale Investment Management first reported a position in BEAT in Q3 2015 and held it in 7 quarters. The position peaked at $1.01M in Q4 2016. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

Hillsdale Investment Management reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
Hillsdale Investment Management sold 9,300 BioTelemetry, Inc. shares in Q2 2019, an estimated $582K.
Hillsdale Investment Management first reported a position in BioTelemetry, Inc. in Q3 2015 and held it in 7 quarters.
Hillsdale Investment Management's BioTelemetry, Inc. position peaked at $1.01M in Q4 2016.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Hillsdale Investment Management's 13F filing for Q2 2019, filed 2 Aug 2019.